Alcohol prep pads recalled over current good manufacturing practice deviations
Quick Touch Alcohol Prep Pads containing 70% isopropyl alcohol, lot 20240610, are recalled for current good manufacturing practice deviations. 500 cases are affected.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Rubric level 2 covers precautionary recalls; the notice cites manufacturing practice deviations without describing any defect or health consequence.
Plain-English summary
Quick Touch Alcohol Prep Pads (Isopropyl Alcohol 70%), 100 sterile pads per carton, from AUM Pharmaceuticals of Hauppauge, New York, are being recalled. The affected product is lot 20240610 with an expiry of 06/2029, and the recall covers 500 cases.
The recall was issued for current good manufacturing practice deviations. The FDA classified the action as Class II. The notice does not describe a specific defect in the product.
Anyone holding this lot should stop using the pads and follow the manufacturer's instructions for return.
The recalled product
- Product
- Quick Touch Alcohol Prep Pads(Isopropyl Alcohol 70%), 100 Sterile Pads per carton, AUM Pharmaceuticals, 320 Oser Ave., Hauppauge, NY 11788.
- Manufacturer
- YANGZHOU YULOU PAPER PRODUCTS CO., LTD
- Category
- Drug — Antiseptic
- Affected units
- 500
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 20240610
- Exp. Date 06/2029
Distribution
Distribution scope not specified by the agency.
Related recalls
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Vancomycin Injection Due to CGMP Deviations
FDA (Drugs) · 2026-09-09